| 前收市價 | 26.26 |
| 開市 | 26.33 |
| 買盤 | 26.35 x 3100 |
| 賣出價 | 0.00 x 2200 |
| 今日波幅 | 26.19 - 26.47 |
| 52 週波幅 | 25.23 - 40.37 |
| 成交量 | |
| 平均成交量 | 42,576,651 |
| 市值 | 149.038B |
| Beta 值 (5 年，每月) | 0.57 |
| 市盈率 (最近 12 個月) | 71.14 |
| 每股盈利 (最近 12 個月) | 0.37 |
| 業績公佈日 | 2024年5月01日 |
| 遠期股息及收益率 | 1.68 (6.38%) |
| 除息日 | 2024年1月25日 |
| 1 年預測目標價 | 31.10 |
Motley FoolBetter Buy: Pfizer vs. Viking Therapeutics
These two pharma stocks have followed distinct paths of late. Which is the better investment?
ReutersPfizer vs Moderna battle over COVID vaccine patents begins in UK
Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a global legal battle began on Tuesday. Pfizer and its German partner BioNTech sued Moderna at London's High Court in September 2022, seeking to revoke patents held by Moderna, which hit back days later alleging its patents had been infringed. Moderna says Pfizer and BioNTech copied mRNA advances it had pioneered and patented well before the COVID-19 pandemic began in late 2019.
ZacksPfizer (PFE) Rises Higher Than Market: Key Facts
Pfizer (PFE) reachead $26.26 at the closing of the latest trading day, reflecting a +1% change compared to its last close.
